Viewing StudyNCT00171301



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171301
Status: COMPLETED
Last Update Posted: 2011-08-31
First Post: 2005-09-12

Brief Title: Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis Study Amended to 2-year Duration
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Beta-thalassemia Major
Hemosiderosis
Iron Overload
Rare Anemia
Keywords:
Name View
iron overload due to transfusion View
Transfusional hemosiderosis View
Beta-thalassemia major View
Deferasirox View
iron overload View
rare anemia View